Organic Active Ingredients TRIZ Cases

A maleate salt of a cyclohexane derivative reduces hygroscopicity through ionic bonding and crystal structure stabilization.

A miRNA-342 molecule regulates gene expression to induce anti-tumor activity in squamous cell carcinoma.

Segmented nifedipine liquid dosage units reduce maternal adverse effects while maintaining tocolytic efficacy.

Replacing invasive surgery, a CBX7 inhibitor treats cerebral cavernous malformations by targeting epigenetic regulators to prevent lesion progression.

Low dose radiation elicits repair mechanisms in non-neoplastic cells, reducing damage to surrounding healthy tissues during cancer therapy.

A Cas9 nickase paired with a 3' to 5' exonuclease processes DNA overhangs to generate precise deletions in target nucleic acids.

Polyvinylpyrrolidone balances tablet hardness against dispersion time, resolving the contradiction between mechanical strength and rapid dissolution.

Modified VWF-targeting aptamers use nucleotide changes and PEGylation to enhance nuclease stability and circulation time.

Segmenting adenosine receptor activity into selective A2A antagonism reduces vascular complications while treating movement disorders.

Antisense oligomers hybridize with interleukin pre-mRNA to alter splicing, resolving inadequate immune therapy specificity.

Carbonate prodrug derivatives of psilocin overcome synthesis complexity and oxidation instability by enabling controlled hydrolysis to release active compounds.

Low-temperature enzymatic extraction preserves volatile compounds while increasing bioavailability to treat skin diseases without steroid-induced atrophy.

Measuring ribosomal protein expression levels identifies glioblastoma patients likely to respond to toxic topoisomerase poisons, avoiding ineffective treatment.

Novel bicyclic urea compounds bypass the stratum corneum barrier to induce melanin production without UV irradiation.

Formula I small organic molecules inhibit C5aR-mediated chemotaxis and anaphylatoxic activity for autoimmune disease treatment.

Administering clemizole or R-chloroquine reduces lobular inflammation and steatosis in non-alcoholic steatohepatitis.

Engineered extracellular vesicles display dual antigen-binding domains to activate immune cells and promote immunological synapse formation.

Optimized drospirenone particle sizes and skipped-dose regimens reduce plasma peaks while maintaining contraceptive efficacy.

A rotating turret supplies multiple die placement heads to a force application rod, eliminating head swapping delays and reducing cycle time.

Monitoring morning cortisol and ACTH concentrations enables prophylactic mineralocorticoid treatment to prevent life-threatening cardiac arrhythmias.

FGF21 agents stimulate oligodendrocyte precursor cell proliferation to regenerate damaged myelin sheaths in the central nervous system.

Segmenting TMC278 into nanoparticles creates a depot effect that maintains viral suppression while reducing dosing frequency and resistance risk.

Macrocyclic compounds modify chemical structures to inhibit hepatitis C virus replication while improving metabolic stability and reducing side effects.

Composite bacterial cellulose film with moisturizing agents resolves the trade-off between high liquid content and structural stability in eye patches.

Quinazoline-2,4-dione derivatives inhibit TRPC5-mediated ion flux to treat neuropsychiatric disorders.

A corticosteroid dispensing system qualifies patients via surveys and phone screening before medication release.

Tartrate salts of quinazoline compounds with zinc-binding moieties enhance solubility and stability for pharmaceutical delivery.

Segmented benzimidazole hexahydrofuro[3,2-b]furan derivatives activate AMPK to improve insulin resistance while reducing side effects.

Compacted nutrient pellets use sequential organic solvent and fatty acid salt coatings to form a protective barrier around the central core.

Soluble substrate coating dissolves in liquid to deliver precise doses while color change confirms complete absorption.

Modifying adenosine structures reduces toxicity while maintaining enzyme inhibition, overcoming limitations of existing cancer therapies.

Combines hyaluronic acid with bone morphogenetic protein for intra-articular injection to promote cartilage regeneration.

Pyridine mediates CPT-11 condensation at room temperature, stabilizing intermediates to resolve low yield and impurity issues.

Merging STAT3 antisense inhibition with PD-L1 blockade overcomes immunosuppressive barriers that limit single-agent efficacy.

Substituted azole dione compounds abrogate the G2 checkpoint, forcing DNA-damaged cancer cells into mitotic catastrophe while sparing normal cells.

Transdermal delivery system with abuse deterrent agents minimizes plasma spikes and side effects while maintaining sustained therapeutic efficacy.

AAV vectors cross the blood-brain barrier to express TPP1, bypassing systemic delivery limits.

Segmented hydrophobic and hydrophilic matrices prevent chemical instability between celecoxib and acetaminophen while maintaining rapid dissolution.

A wearable grid stimulates specific nocipoints to trigger a neuroimmune cascade that recruits stem cells for tissue repair.

Glucosylglycerol serves as an active ingredient in ophthalmic formulations to protect the keratoconjunctiva from drying.

Administering tramadol before plasma exchange blocks NMDA receptors to enhance antibody removal.

Silvestrol targets host eIF4A helicase to block cap-dependent translation in RNA viruses like Ebola and Coronaviruses.

CERT S132A overexpression in CHO cells resolves the trade-off between high protein secretion and cell growth inhibition.

Formula I compounds with specific heterocyclic moieties overcome bacterial resistance mechanisms while maintaining treatment effectiveness.

Novel sotagliflozin crystal forms address poor stability under high water activity by modifying solvent systems to achieve uniform particle morphology.

Novel KRAS inhibitors target G12D mutants via localized chemical features, resolving selectivity and oral bioavailability trade-offs.

Novel pyrazolo[3,4-d]pyrimidine compounds target Wee1 kinase to induce apoptosis in p53-deficient tumors while improving clinical selectivity.

A melt-processed dosage form using tocopheryl compounds and propylene glycol fatty acid monoesters prevents drug recrystallization to enhance bioavailability.

A micronutrient composition enhances testosterone production through synergistic ingredient combinations.

A peptide-oligonucleotide conjugate delivers anti-miRNA inhibitors to cancer cells and macrophages.

An adipocyte-targeting DNA nanodrug uses aptamers to deliver tannic acid, reducing lipid accumulation and inflammation while minimizing systemic side effects.

C-Src inhibitors target airway basal cells to block profibrotic signaling, preventing early-stage lung fibrosis progression.

Administering MELK inhibitors targets estrogen receptor negative breast cancer cells to suppress tumor growth and proliferation.

Essential amino acid composition enhances muscle protein synthesis without burdening digestive efficiency in elderly individuals.

Administering CD105+ placental stem cells reduces osteoclast activity and bone lesions in multiple myeloma patients.

Indazolyl triazole compounds inhibit IRAK-4 and IRAK-1 kinase activity to treat inflammatory disorders.

GCN2 and PERK kinase inhibitors disrupt the GCN2/ATF4 pathway to enhance asparaginase sensitivity and suppress tumor growth.

Quinuclidine compounds inhibit glucosylceramide synthase to address pain and angiokeratoma unmet by enzyme replacement therapy.

BDDE cross-linking produces nanostructured hyaluronic acid filterable at 0.2 microns, avoiding thermal degradation during sterilization.

Fused heteroaryl derivatives antagonize orexin receptors, addressing the lack of effective treatments for sleep disorders and psychiatric conditions.

A risperidone depot formulation uses a high viscosity lipid carrier and lactic acid polymer for controlled release.

A parenteral dosage form releases anastrozole and levonorgestrel locally to treat endometriosis without systemic estrogen deficiency.

Granulated C-005 citrate tablets with solubilizers achieve rapid dissolution, reducing inter-patient absorption variability.

Organic solvent heat treatment removes bacteria and endotoxins while preventing hydrolytic degradation of polysaccharide chains.

Heteroaryl compounds inhibit aldosterone synthase to lower hormone levels and address pro-inflammatory effects in diabetic nephropathy.

Deuterium-enriched pioglitazone replaces hydrogen protons with deuterium atoms to increase isotopic content above natural abundance levels.

Ethylene vinyl alcohol copolymers resolve chemical migration and moisture permeability issues by providing anti-scalping properties and reliable heat sealing.

Multi-target benzodiazepine derivative treats neurodegenerative disorders via combined pharmacological action.

Injectable microparticles extend naltrexone release to 100 days, eliminating surgical implantation requirements.

Heteroarylene-bridged benzodiazepine dimers resolve off-target toxicity by enabling selective delivery of cytotoxic payloads to tumor-associated antigens.

Deazaguanine compounds inhibit V617F variant kinase activity while preserving wild-type function via localized binding pocket interactions.

Pyrazolopyridine derivatives target NaV1.3 and NaV1.7 channels while sparing NaV1.5, reducing systemic toxicity.

Combines HDAC6 and BCL-2 inhibitors to treat resistant cancers while reducing adverse effects from broad inhibition.

Hydrazide-based contrast agents localize to necrotic tissue, resolving diagnostic ambiguity by differentiating pathological signals from normal background.

Substituted phenothiazines modulate the ABCC1 transporter to reduce cerebral beta-amyloid load.

SMIFH2 derivatives block IFN-gamma JAK/STAT signaling to treat autoimmune diseases with reduced side effects.

Administering grape seed extract before meals activates antioxidant defenses to reduce postprandial glucose response and inflammation.

Albumin-bound taxane nanoparticles improve progression-free survival in metastatic melanoma by targeting albumin receptors on cancer cells.

Antisense oligomers target FcεRIβ mRNA splicing to lower receptor expression, avoiding side effects from broad-spectrum glucocorticosteroids.

Pyrazole derivatives target Trk and JAK kinases, resolving inadequate therapeutic outcomes in cancer treatment.

A stable lyophilizate dosage form of the etidronate-cytarabine conjugate incorporates a divalent metal salt to maintain hydrolytic and physical stability.

A pharmaceutical gel formulation containing aripiprazole utilizes specific solvent systems to enhance skin permeation.

Novel quinolizine derivatives inhibit hepatitis B surface antigen production.

Thymosin alpha 1 promotes immune tolerance through thymic peptide activity.

Filter-based electrochemical sensor quantifies delta-9-tetrahydrocannabinol in exhaled breath, enabling rapid roadside testing without invasive blood draws.

Novel amine-substituted heterocyclic compounds inhibit EHMT1 and EHMT2 enzymes to treat blood disorders.

Selective REV-ERBα agonist treatment prevents cardiac hypertrophy progression and reduces fibrosis without relying on symptomatic relief.

Pre-administered autologous exosomes inhibit Kupffer cell sequestration, enabling nanoparticle accumulation in target tissues.

Isoquinolinone derivatives act as potent NK3 antagonists to treat psychosis.

A crystalline intermediate enables efficient candesartan cilexetil production.

Combining hydrophobically modified inulin with hydrophilic acrylic polymers stabilizes high-oil emulsions.

Phenylbutyric acid eyedrops target the PERK and ATF6 pathways to inhibit scleral thinning, addressing axial elongation in myopic eyes.

Pulsed incoherent light facilitates transdermal delivery of large molecular weight biologically active substances without damaging the stratum corneum.